Quality System Upgrade to ISO 13485:2003

04/21/2006. Berkeley Advanced Biomaterials, Inc. has upgraded the Quality System from ISO 13485:1996 to 13485:2003. Download the Registration Certificate

Orthofix in Agreement with Berkeley Advanced Biomaterials to Market and Distribute Bone Repair Resorbable Biomaterials for Trauma and Reconstruction Applications

HUNTERSVILLE, N.C., & BERKELEY, Calif.--(BUSINESS WIRE)--April 26, 2005-- Agreement enables Orthofix to provide orthopedic surgeons with a synthetic bone graft solution for filling bone voids during surgery. READ MORE>>

FDA Approval to Market Tri-Ostetic™

07/06/2004. The U.S. Food and Drug Administration has approved an innovative bone fill product from Berkeley Advanced Biomaterials, Tri-Ostetic™. Download FDA Summary Statement

Nationwide Launch of New Biomaterial: DyNoss®

MAITLAND, FLORIDA — June 14th, 2004 — Scient’x USA announces today the nationwide launch of their New Synthetic Cancellous Bone Void Filler: DyNoss®. READ MORE>

FDA Approval to Market Cem-Ostetic® Bone Injection Kit

02/10/2004. The U.S. Food and Drug Administration has approved an innovative bone fill product from Berkeley Advanced Biomaterials, Cem-Ostetic® Bone Injection Kit. Download FDA Summary Statement

Berkeley Advanced Biomaterials Granted FDA Approval
to Market Bi-Ostetic™ in U.S.

01/30/2003 Berkeley, California. The U.S. Food and Drug Administration has approved two products from Berkeley Advanced Biomaterials, Bi-Ostetic™ granules and Bi-Ostetic™ blocks. The company's Ostetic product line of synthetic bone fillers provides high quality, cost effective solutions for orthopedic care. READ MORE >>

Berkeley Advanced Biomaterials Granted FDA Approval
to Market Cem-Ostetic® Injectable Putty in U.S.

01/09/2003 Berkeley, California. The U.S. Food and Drug Administration has approved an innovative bone fill product from Berkeley Advanced Biomaterials, Cem-Ostetic® Putty. READ MORE >>